Literature DB >> 21060007

Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension.

Oded Friedman1, T Douglas Bradley, Christopher T Chan, Robert Parkes, Alexander G Logan.   

Abstract

Obstructive sleep apnea occurs frequently in patients with drug-resistant hypertension. The factors accounting for this observation, however, are unclear. Both conditions demonstrate clinical features suggestive of extracellular fluid volume overload. The aims of this study were to examine whether the spontaneous overnight fluid shift from the legs to the upper body is associated with obstructive sleep apnea in hypertensive subjects and whether its magnitude is greater in drug-resistant hypertension. Leg fluid volume and the circumference of the calf and neck were measured before and after sleep in drug-resistant hypertensive (n = 25) and controlled hypertensive (n=15) subjects undergoing overnight polysomnography. The severity of obstructive sleep apnea was greater in the drug-resistant hypertensive group than in the controlled hypertensive group (apnea-hypopnea index: 43.0 ± 5.4 versus 18.1 ± 4.2 events per hour of sleep; P = 0.02, case-mix adjusted). In both groups, the apnea-hypopnea index strongly related to the amount of leg fluid volume displaced (R² = 0.56; P < 0.0001), although the magnitude of change was greater in the drug-resistant hypertensive group (346.7 ± 24.1 versus 175.8 ± 31.3 mL; P = 0.01, propensity-score adjusted). The overnight reduction in calf circumference and increase in neck circumference were also greater in drug-resistant hypertension (both P ≤ 0.02). In hypertensive subjects, rostral fluid displacement strongly relates to the severity of obstructive sleep apnea with its magnitude being greater in drug-resistant hypertension. Our findings support the concept that fluid redistribution centrally during sleep accounts for the high prevalence of obstructive sleep apnea in drug-resistant hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21060007     DOI: 10.1161/HYPERTENSIONAHA.110.154427

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  54 in total

Review 1.  Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov
Journal:  Sleep Breath       Date:  2012-08-08       Impact factor: 2.816

2.  Influence of rostral fluid shift on upper airway size and mucosal water content.

Authors:  Takatoshi Kasai; Shveta S Motwani; Rosilene M Elias; Joseph M Gabriel; Luigi Taranto Montemurro; Naotake Yanagisawa; Neil Spiller; Narinder Paul; T Douglas Bradley
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

Review 3.  Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea.

Authors:  Laura H White; T Douglas Bradley
Journal:  J Physiol       Date:  2012-12-10       Impact factor: 5.182

Review 4.  Obstructive sleep apnea and hypertension: is the primary link simply volume overload?

Authors:  Jonathan Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 5.  Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure.

Authors:  Gianfranco Parati; Martino Francesco Pengo; Carolina Lombardi
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

6.  Resistant hypertension and obstructive sleep apnea in the setting of kidney disease.

Authors:  Khaled Abdel-Kader; Sheena Dohar; Nirav Shah; Manisha Jhamb; Steven E Reis; Patrick Strollo; Daniel Buysse; Mark L Unruh
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

Review 7.  Management of Hypertension in Obstructive Sleep Apnea.

Authors:  Sofia F Furlan; Caio V Braz; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

8.  Resistant hypertension and untreated severe sleep apnea: slowly gaining insight.

Authors:  Susan M Harding
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

Review 9.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

10.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.